Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML.
Options
Publisher DOI
PubMed ID
30998101
Date of Publication
2019-10
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Shumilov, Evgenii | |
Flach, Johanna | |
Gfeller, Eva |
Series
Leukemia & lymphoma
Publisher
Taylor & Francis
ISSN
1029-2403
Access(Rights)
metadata.only